Skip to main content
Top

The molecular pathophysiology of chronic non-bacterial osteomyelitis (CNO)—a systematic review

  • Open Access
  • 01-12-2017
  • Mini review
Published in:

Abstract

Chronic non-bacterial osteomyelitis (CNO) belongs to the growing spectrum of autoinflammatory diseases and primarily affects the skeletal system. Peak onset ranges between 7 and 12 years of age. The clinical spectrum of CNO covers sometimes asymptomatic inflammation of single bones at the one end and chronically active or recurrent multifocal osteitis at the other.
Despite the intense scientific efforts, the exact molecular mechanisms of CNO remain unknown. Recent data suggest CNO as a genetically complex disorder with dysregulated TLR4/MAPK/inflammasome signaling cascades resulting in an imbalance between pro- and anti-inflammatory cytokine expression, leading to osteoclast activation and osteolytic lesions.
In this manuscript, the current understanding of molecular patho-mechanisms in CNO will be discussed.
Title
The molecular pathophysiology of chronic non-bacterial osteomyelitis (CNO)—a systematic review
Authors
Sigrun Ruth Hofmann
Franz Kapplusch
Katrin Mäbert
Christian Michael Hedrich
Publication date
01-12-2017
Publisher
Springer Berlin Heidelberg
Published in
Molecular and Cellular Pediatrics / Issue 1/2017
Electronic ISSN: 2194-7791
DOI
https://doi.org/10.1186/s40348-017-0073-y
This content is only visible if you are logged in and have the appropriate permissions.

Mini masterclass: enhancing outcomes in LGS (Link opens in a new window)

1.5 AMA PRA Category 1 Credit(s)

These six bite-sized videos will equip you with insights into the pathophysiological processes underlying Lennox–Gastaut syndrome, the burden on patients and caregivers, and opportunities to increase diagnostic accuracy and optimize treatment strategies.

Independent Medical Education Grant:
  • Jazz Pharmaceuticals
Watch now TODO (Link opens in a new window)

Keynote webinar | Spotlight on adolescent vaping

Growing numbers of young people are using e-cigarettes, despite warnings of respiratory effects and addiction. How can doctors tackle the epidemic, and what health effects should you prepare to manage in your clinics?

Prof. Ann McNeill
Dr. Debbie Robson
Benji Horwell
Watch now
Video
Image Credits
Enchancing Lennox-Gastaut Syndrome program image/© Springer Health+ IME, Person in orange t-shirt using an e-cigarette/© licsiren / Getty Images / iStock (symbolic image with model)